US20020016630A1 - Multifocal phakic intraocular lens - Google Patents
Multifocal phakic intraocular lens Download PDFInfo
- Publication number
- US20020016630A1 US20020016630A1 US09/960,032 US96003201A US2002016630A1 US 20020016630 A1 US20020016630 A1 US 20020016630A1 US 96003201 A US96003201 A US 96003201A US 2002016630 A1 US2002016630 A1 US 2002016630A1
- Authority
- US
- United States
- Prior art keywords
- lens
- eye
- intraocular lens
- power
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- FVVGXRJNWIYMNJ-UHFFFAOYSA-N CC(C1)C1(C)N Chemical compound CC(C1)C1(C)N FVVGXRJNWIYMNJ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1602—Corrective lenses for use in addition to the natural lenses of the eyes or for pseudo-phakic eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1616—Pseudo-accommodative, e.g. multifocal or enabling monovision
- A61F2/1618—Multifocal lenses
Definitions
- IOLs Intraocular lenses
- IOLs are commonly used to modify vision.
- IOLs are used to replace the natural lens of the eye when warranted by medical conditions.
- a common practice is to implant an IOL in a region of the eye known as the capsular bag or posterior capsule after the natural lens has been removed.
- IOLs may be implanted in regions of the eye other than in the capsular bag.
- monofocal IOLs that is IOLs which have a single vision correction power
- monofocal IOLs have been implanted in the anterior chamber at the front of the eye, even with the crystalline natural lens remaining in place.
- monofocal IOLs have been implanted in the posterior chamber even with the natural crystalline lens being present.
- Such monofocal IOLs are designed to correct a single vision deficiency, for example, myopia, present in the eye.
- presbyopia Over time, as a human ages, the normal human eye gradually loses the ability to accommodate, that is to focus on objects located at different distances from the eye. This loss of accommodation is generally identified as presbyopia.
- the natural lens may remain clear and otherwise functional in directing light to the retina of the eye.
- spectacles are often used to correct the presbyopia.
- degrees of presbyopia that are, at least generally, related to the age of the human subject. For example, early stages of presbyopia may occur in individuals in their twenties, and residual accommodation of the natural lens may remain in individuals in their sixties, seventies and beyond. Many people wish to avoid wearing spectacles, particularly in their younger years, to maintain a youthful appearance.
- Intraocular lenses for use in mammalian eyes having natural lenses have been discovered. Such IOLs are particularly useful in phakic eyes in which the natural lens has lost a degree of accommodation or accommodative ability, that is in a partially presbyopic eye.
- the present IOLs have multiple optic powers, that is are multifocal, preferably having an optic power for each object distance at which an object is formed on the retina.
- the multifocal design of the lens preferably is mechanically fixed so that the multiple optical powers can operate substantially simultaneously.
- IOLs are provided for use in mammalian eyes having natural lenses.
- Such IOLs comprise a lens body sized and adapted for placement in the eye and having a baseline optical power and at least one optical add power, preferably a plurality of different optical add powers.
- At least one of the optical add powers, preferably each of the add powers, is reduced compared to the baseline optical power of the lens body relative to the corresponding optical power of a similar intraocular lens adapted for placement in a similar eye in which the natural lens has been removed.
- Such reduced optical add power or powers provide only partial restoration of accommodation. In other words, the reduced optical power or powers of the IOL alone do not provide for full accommodation.
- the reduced optical power or powers of the present IOLs when combined with the residual natural accommodative ability in the early or partial presbyopic phakic eye, provide enhanced vision, for example, enhanced near vision.
- IOLs are provided for use in mammalian eyes including natural lenses having accommodative capability.
- the IOLs comprise a lens body sized and adapted for placement in the mammalian eye and having a baseline optical power and at least one optical add power, preferably a plurality of different optical add powers.
- At least one of the optical add powers, preferably each of the optical add powers of the lens body has a magnitude so that the lens body when placed in the mammalian eye, in combination with the natural lens, provides enhanced vision. This enhanced vision continues as the accommodative capability of the natural lens in the eye decreases.
- the magnitude of the add power or powers of the lens body may provide only partial restoration of full accommodation in and of itself.
- such IOL when combined with the residual natural accommodative ability in the early presbyope, such IOL provides enhanced vision, for example, enhanced, or even substantially full, near vision or reading vision ability. Even after the early or partial presbyopic subject or presbyope progresses to full or absolute presbyopia, often after more than about five (5) or about ten (10) or about twenty (20) or more years, the reduced add power or powers of the present IOLs provide enhanced vision, for example, at intermediate distances.
- the IOLs in accordance with the present invention preferably provide a range of optical powers to allow focusing of distance, intermediate and near images on the retina.
- the IOL has a simultaneous vision design, that is a concentric and cylindrically symmetric series of zones, such as annular zones, of varying optical power which provide additional or add power for vision at other than distance.
- the designed principal optical add power, in particular a near optical power, of the present IOLs preferably is less than the full optical power required for near reading in a pseudophakic subject, that is a subject not having a natural lens in place. This reduced power preferably is less than about 2.5 diopters in the spectacle plane. In a very useful embodiment, the designed principal optical add power of the IOL is reduced, which, in turn, reduces the effects of halos around lights at night while providing acceptable near and/or intermediate vision correction.
- the present IOLs preferably provide continuous visual correction or enhancement from distance to near for early (or partial) presbyopes.
- late or absolute presbyopes gradually find a reduction in near vision capabilities employing the present IOLs.
- additional vision e.g., spectacle
- the additional optical power required for near work is less than that which would be required without the present IOLs. This reduced optical power requirement allows the use of bifocals or progressive spectacles which have fewer field distortions, image jumping and other deleterious visual effects.
- the present IOLs may be placed at any position along the optical axis of the eye.
- the present IOLs can be carried by or secured to the cornea of the eye, for example, such as a corneal implant, e.g., inlay or onlay.
- the IOLs can be placed posterior of the posterior chamber.
- the present IOLs may further comprise a fixation member or members coupled to the lens body and adapted to facilitate fixating the IOL in the eye.
- the fixation member or members preferably are adapted to be placed in the anterior chamber of a mammalian eye or in the posterior chamber of a mammalian eye.
- the design of the present IOLS preferably provides that the lens body include a plurality of different regions each having an optical power, for example, a different optical power.
- the lens body may include a plurality of annular regions each having an optical power and extending radially outwardly from the central axis of the lens body.
- the lens body preferably is generally circular around the optical axis of the lens body, although other configurations and shapes may be employed and are within the scope of the present invention.
- the lens body preferably is configured so that at least one of the optical add powers is reduced by at least about 10%, and more preferably at least about 20% (in terms of diopters from a baseline distance correction optical power) relative to the corresponding optical power of the similar IOL adapted for placement in a similar eye in which a natural lens has been removed. Still more preferably, each of the add powers in the lens body is reduced by at least about 10% and even more preferably at least about 20%, relative to the corresponding optical power of the similar IOL adapted for placement in a similar eye in which the natural lens has been removed.
- the present lens bodies preferably are deformable for insertion through a small incision into the mammalian eye.
- the lens bodies preferably comprise a polymeric material.
- FIG. 1 is a side elevation view of an eye with an anterior chamber intraocular lens in accordance with the present invention implanted therein.
- FIG. 2 is a front plan view of the anterior chamber intraocular lens shown in FIG. 1.
- FIG. 3 is a plot of the power of the lens body of the intraocular lens shown in FIG. 1 versus distance from the optical axis of the intraocular lens.
- FIG. 4 is a side elavational view of an eye with a posterior intraocular lens in accordance with the present invention implanted therein.
- FIG. 5 is a perspective view of the intraocular lens shown in FIG. 4.
- FIG. 6 is a side elevational view of an eye with another embodiment of an intraocular lens in accordance with the present invention implanted therein.
- FIG. 7 is a perspective view of the intraocular lens shown in FIG. 6.
- an intraocular lens (IOL) according to the present invention, shown generally at 10 , includes a multifocal lens body 12 having a plurality of optical powers, as described hereinafter. Radially extending fixation members or haptics 14 terminate in distal ends 16 . As shown in FIG. 1, intraocular lens 10 is inserted in the anterior chamber 18 of eye 20 with the distal ends 16 of fixation members 14 in contact with the angle 22 of the iris 24 .
- any number of configurations can be employed for distal ends 16 of fixation members 14 in order to provide for effective fixation of intraocular lens 10 in anterior chamber 18 .
- the configuration chosen be effective to provide for such fixation while, at the same time, not having an undue detrimental effect on the angle of the anterior chamber or on other components of eye 20 .
- the intraocular lens 10 is useful in eyes suffering from the early stages of presbyopia.
- the intraocular lens 10 should be designed and configured for long term use, for example, in excess of about ten (10) or about twenty (20) or thirty (30) years or more, in eye 20 .
- fixation members 14 can be made of materials of construction, such as polymeric materials, for example, polypropylene, polymethyl methacrylate and the like, many of which are conventionally used in intraocular lens haptics.
- the lens body 12 may be constructed of rigid biocompatible materials such as polymethyl methacrylate (PMMA), or flexible, deformable materials, such as silicone polymeric material, acrylic polymeric material, hydrogel polymeric material and the like, which enable the lens body to be rolled or folded before insertion through a small incision into the eye 20 .
- PMMA polymethyl methacrylate
- the present IOLs can include a diffractive lens body and such embodiment is included within the scope of the present invention.
- the power curve of lens body 12 seen in FIG. 3, is illustrative, but not limiting, of the present invention.
- lens bodies or optics in accordance with the present invention can have any suitable configurations and/or power curves effective to function, for example, to provide one or more benefits, as described herein.
- IOL 10 One important aspect of IOL 10 relates to the reduced add power of the optical powers of lens body 12 .
- the power curve for the lens body 12 is shown as a solid line in FIG. 3.
- the add power or magnitude of the optical power relative to the baseline or “X” axis of FIG. 3 is reduced relative to the add power of a similar lens body, shown in dashed lines in FIG. 3, of a similar IOL adapted for use in an eye in which the natural lens has been removed.
- the optical power of the lens body 12 remains relatively closer to the baseline power (defined as the “X” axis in FIG. 3) as compared to the optical power of a similar lens body adapted for use in an eye in which the natural lens has been removed.
- the amount of reduction in the add power (relative to the above-noted similar lens adapted for use in an eye in which the natural lens has been removed) may be as little as about 10% or about 20%, such reduction in the add power is often greater than about 20% and can be in the range of about 30% to about 50% or more.
- IOL 10 is very effective when inserted into an eye of an early presbyope, that is into the eye of a subject (e.g., human) who suffers a degree of, but not total, presbyopia.
- the reduced add power of IOL 10 is effective, in combination with the remaining or residual accommodating ability of the natural lens 50 , to provide for substantially full accommodation, particularly in the early presbyope in which the loss of accommodating ability is less than about 20% or about 30% or about 50%.
- the add powers of the lens body 12 are determined, controlled or based, at least in part, by one or more of the following factors: the degree of residual or remaining accommodating ability of the natural lens 50 , the age of the subject in whose eye the IOL 10 is to be inserted, the vision needs of the subject, and the expected or anticipated life span of the subject, among other factors many of which are personal to the subject.
- the present IOL 10 is often customized to meet the specific and individual needs of the subject in whose eye the IOL 10 is to be inserted.
- the lens body 12 provides enhanced vision, particularly for near objects which such early presbyopes often have difficulty in viewing.
- enhanced near vision is provided without the need for spectacles or other vision aids which can have at least a perceived detrimental effect on the appearance of the subject.
- the IOL 10 continues to provide enhanced vision, for example, enhanced vision in viewing objects at intermediate distances.
- the later or substantially complete presbyope may require spectacles for viewing near objects.
- the presence of IOL 10 in the eye 20 allows use of bifocals and progressive spectacles which have reduced field distortions, image “jumping” and other detrimental visual effects.
- An additional advantage of the reduced add power of IOL 10 is a reduction in the effects of halos around lights, for example, when viewed from a distance, at night.
- anterior chamber IOL 10 shown in FIG. 1 One particular advantage of the anterior chamber IOL 10 shown in FIG. 1 is that a substantial distance is maintained between the natural lens 50 and the lens body 12 . This distance is very effective in providing protection against the IOL 10 touching and possibly harming the natural lens 50 .
- the lens body 12 has a convex anterior surface 25 and a planar posterior surface 27 ; however, these configurations are merely illustrative. Although the vision correction power may be placed on either of the surfaces 25 or 27 , in this embodiment, the anterior surface 25 is appropriately shaped to provide the desired vision correction powers.
- the lens body 12 has a central zone 28 , inner and outer annular near zones 29 and 30 and annular far zones 31 , 32 and 33 .
- the central zone 28 is circular and the peripheries of the annular zones 29 - 33 are circular.
- the annular zones 29 - 33 circumscribe the central zone 28 and the zones are contiguous.
- the zones 29 - 33 are concentric and coaxial with the lens body 12 .
- the zones 28 - 33 are used in describing the vision correction power of the lens body 12 , and they are arbitrarily defined.
- FIG. 3 shows a preferred manner in which the vision correction power of the lens body 12 varies from the center or optical axis 39 of the lens body to the circular outer periphery 41 of the lens body.
- the vertical or “Y” axis represents the variation in diopter power of the lens body 12 from the baseline or far vision correction power
- the “X” or horizontal axis shows the distance outwardly from the optical axis 39 , for example, in millimeters.
- the zero-diopter or baseline power of FIG. 3 is the power required for far vision for an IOL.
- the power variation shown in FIG. 3 is applicable to any surface point on lens body 12 at a fixed radial distance from the optical axis 39 . In other words, the power at any given radial distance from the optical axis 39 is the same.
- the central zone 28 extends from the optical axis 39 to a circular periphery 43
- the inner annular near zone 29 is considered as extending from the periphery 43 to a circular periphery 44
- the outer annular near zone is considered as extending from a periphery 45 to a periphery 46
- the annular far zone 31 extends between the peripheries 44 and 45
- the annular far zone 32 extends from the periphery 46 radially outwardly to a periphery 47
- the annular zone 33 extends from the periphery 47 radially outwardly to the outer periphery 41 of the lens body 22 .
- the negative diopter powers at the optical axis and the point 49 are of less power than is required for far vision and may be considered as far, far vision correction powers.
- the actual correction provided by the plurality of optical powers will vary and depends, for example, on the amount of residual accommodative ability present in natural lens 50 , among other factors.
- the apex 48 has a vision correction power for intermediate vision.
- the intermediate, far and far, far powers combine to provide a mean power in the central zone 28 for far or distant vision.
- the vision correction power varies from the periphery 43 to a plateau 51 , and from the plateau, the vision correction power varies back to the periphery 44 at the baseline.
- the vision correction power increases very slightly above the baseline and then proceeds to a far, far negative vision correction power at a point 53 at which the vision correction power reverses and returns to the baseline at the periphery 45 .
- the power varies from the periphery 45 to a plateau 55 and returns from the plateau 55 to the baseline at the periphery 46 .
- the power dips slightly below the baseline to a point 57 in the far, far correction region and then returns to the baseline at the outer periphery 47 .
- the dips below the baseline to the points 53 and 57 in the far zones 31 and 32 help support an increased depth of the focus of the central zone 28 .
- the far zone 33 has a vision power that lies along the baseline and is configured for far vision.
- FIGS. 4 and 5 An alternate embodiment of an IOL in accordance with the present invention is shown in FIGS. 4 and 5. Except as expressly described herein, this alternate IOL, shown generally at 110 , is structured and functions similarly to IOL 10 . Components of IOL 110 which correspond to components of IOL 10 are indicated by the same reference numeral increased by 100 .
- IOL 110 is adapted to be placed in the posterior chamber 59 , that is behind the iris 124 of eye 120 .
- the fixation members 114 are less likely to cause damage to the eye than are the fixation members 14 of IOL 10 .
- fixation members 114 because of their placement, may be somewhat different in structure than the fixation members 14 .
- the lens body 112 is a convex/concave lens.
- the concave posterior face 127 is so configured to provide some degree of space between natural lens 150 and lens body 112 . Again, it is important that the lens body 112 be spaced apart from the natural lens 150 in order to avoid damaging the natural lens.
- the multifocal structure of the lens body 112 preferably is present on the convex anterior face 125 of the lens body 112 .
- IOL 110 performs substantially similarly to IOL 10 , to provide enhanced vision both for the early presbyope subject and the subject who is in the later stages of presbyopia or is a substantially full or complete presbyope, as described above.
- FIGS. 6 and 7 show another embodiment of an IOL in accordance with the present invention. Except as expressly described herein, this further embodiment of the present IOLs, shown as 210 , is structured and functions similarly to IOL 10 . Components of IOL 210 which correspond to components of IOL 10 are indicated by the same reference numeral increased by 200 .
- the further embodiment of IOL 210 provides that the lens body 212 is located in the anterior chamber but the fixation members are structured so as to contact the sulcus 62 in the posterior chamber 64 of the eye 220 .
- This feature provides for both increased spacing between the lens body 212 and the natural lens 250 and, in addition, allows the fixation members 214 to come in contact with the more sturdy sulcus 62 in fixating the IOL 210 in the eye 220 .
- FIG. 7 shows IOL 210 comprised of a lens body 212 , and two opposing elongated fixation members or haptics 214 .
- Each fixation 214 has a proximal segment 66 attached to the lens body 212 near the periphery of the lens body.
- Each fixation member also has a distal segment 68 and an intermediate segment 70 joining the proximal segment 66 and the distal segment.
- the distal segment 70 preferably is more flexible than the other portions of each of the fixation member 214 .
- distal segment 68 can have a reduced cross-sectional area relative to the cross-sectional areas of intermediate segment 70 and proximal segment 66 .
- the lens body 212 in the shown embodiment is circular in plan and bi-convex.
- Each fixation member 214 defines an arc that extends generally normal to the optical axis 239 . Each has a discontinuity or a through-iris portion 72 of the intermediate segment 70 . The through-iris portion 72 extends generally parallel to the optical axis 239 . Other embodiments of the invention may have other suitable arrangements for the fixation members 214 and the through-iris portions 72 . In the shown embodiment, the haptics 214 are symmetrical. Other embodiments of the invention may have non-symmetrical fixation members. In the shown embodiment of the invention, the fixation members 214 extend generally tangentially away from the lens body. Other embodiments of the invention may have fixation members 214 attached to the lens body 212 which extend in a non-tangential fashion.
- each through-iris portion 72 may extend in any suitable direction other than normal to the optical axis 239 .
- each through-iris portion 72 includes a straight member extending generally parallel to the optical axis 239 .
- the IOL 210 is implanted such that the lens body 212 and the proximal segments 66 of the fixation members 214 are disposed in the anterior chamber 218 . With the lens body 212 in the anterior chamber 218 , there is a reduced opportunity for the IOL 210 to contact the natural lens 250 and initiate papillary block and cataract formation. Further, the distal segments 68 of fixation members 214 are disposed in the posterior chamber 64 against the sulcus 62 , which reduces the incidence of harm to the angle of the anterior chamber.
- IOLs having fixation members and being positioned in the eye as IOL 210 are provided in commonly assigned U.S. Patent application Ser. No. 09/166,328 filed Oct. 5, 1998, the disclosure of which is incorporated herein in its entirety by reference.
- IOL 210 performs substantially similarly to IOL 10 , to provide enhanced vision both for the early presbyope subject and the subject who is in the later stages of presbyopia or is a substantially full or complete presbyope, as described above.
- the present IOLs very effectively provide for enhanced vision for presbyopes whether in the early or partial stages of the condition or in the latter or even substantially complete stages.
- the present IOIs can be implanted into an eye having an early or partial form of presbyopia.
- the reduced optical power or powers in combination with the remaining accommodation ability of the natural lens in the eye, preferably provide for a restoration of full accommodation so that the subject can read and perform other near vision activities without the need for spectacles or other vision aids.
- the presbyopia progresses over time with advancing age of the subject, the amount of residual accommodation in the natural lens continues to be reduced.
- the present IOLs are very effective in providing for enhanced vision to the subject, particularly at intermediate distances. At this stage, reading or other near vision activities may require spectacles. Also, because the present IOLs are designed to maintain the eye in good condition and the natural lens in good condition, there is reduced risk that further ocular surgery will be required, for example, to remove the natural lens.
Abstract
Description
- This invention relates to multifocal intraocular lenses. More particularly, the invention relates to multifocal intraocular lenses adapted for use in a phakic eye, that is in an eye which also includes the natural lens.
- Intraocular lenses (IOLs) are commonly used to modify vision. For example, IOLs are used to replace the natural lens of the eye when warranted by medical conditions. A common practice is to implant an IOL in a region of the eye known as the capsular bag or posterior capsule after the natural lens has been removed.
- IOLs may be implanted in regions of the eye other than in the capsular bag. For example, monofocal IOLs, that is IOLs which have a single vision correction power, have been implanted in the anterior chamber at the front of the eye, even with the crystalline natural lens remaining in place. In addition, monofocal IOLs have been implanted in the posterior chamber even with the natural crystalline lens being present. Such monofocal IOLs are designed to correct a single vision deficiency, for example, myopia, present in the eye.
- Neilsen U.S. Pat. No. 5,158,572 discloses a multifocal intraocular lens useful primarily as a replacement for the natural lens, for example, after a lens extraction operation in which the natural lens is removed. This patent very briefly discloses that the intraocular lens can in some cases be used as an adjunct to the natural lens. However, this patent does not disclose any further special or even specific characteristics of a multifocal intraocular lens used in conjunction with a natural lens as opposed to such a multifocal lens used after natural lens extraction.
- Over time, as a human ages, the normal human eye gradually loses the ability to accommodate, that is to focus on objects located at different distances from the eye. This loss of accommodation is generally identified as presbyopia. The natural lens may remain clear and otherwise functional in directing light to the retina of the eye. In this situation, spectacles are often used to correct the presbyopia. In addition, there are varying degrees of presbyopia that are, at least generally, related to the age of the human subject. For example, early stages of presbyopia may occur in individuals in their twenties, and residual accommodation of the natural lens may remain in individuals in their sixties, seventies and beyond. Many people wish to avoid wearing spectacles, particularly in their younger years, to maintain a youthful appearance.
- It would be advantageous to provide an intraocular lens adapted for enhanced effectiveness in an eye including a natural lens.
- Intraocular lenses (IOLs) for use in mammalian eyes having natural lenses have been discovered. Such IOLs are particularly useful in phakic eyes in which the natural lens has lost a degree of accommodation or accommodative ability, that is in a partially presbyopic eye. The present IOLs have multiple optic powers, that is are multifocal, preferably having an optic power for each object distance at which an object is formed on the retina. The multifocal design of the lens preferably is mechanically fixed so that the multiple optical powers can operate substantially simultaneously.
- An important feature of the present IOLs is that they are configured to take into account the remaining accommodation ability or capability of the natural lens so that enhanced vision is obtained irrespective of the degree of presbyopia present. Put another way, the present IOLs are configured or customized to take into account the specific degree of presbyopia present in the eye in which the IOL is to be implanted. The present IOLs can be made using conventional materials of construction and conventional manufacturing techniques and can be implanted in the eye using procedures which are conventionally employed in implanting other monofocal or multifocal IOLs.
- In one broad aspect of the present invention, IOLs are provided for use in mammalian eyes having natural lenses. Such IOLs comprise a lens body sized and adapted for placement in the eye and having a baseline optical power and at least one optical add power, preferably a plurality of different optical add powers. At least one of the optical add powers, preferably each of the add powers, is reduced compared to the baseline optical power of the lens body relative to the corresponding optical power of a similar intraocular lens adapted for placement in a similar eye in which the natural lens has been removed. Such reduced optical add power or powers provide only partial restoration of accommodation. In other words, the reduced optical power or powers of the IOL alone do not provide for full accommodation. However, the reduced optical power or powers of the present IOLs, when combined with the residual natural accommodative ability in the early or partial presbyopic phakic eye, provide enhanced vision, for example, enhanced near vision.
- In another broad aspect of the present invention, IOLs are provided for use in mammalian eyes including natural lenses having accommodative capability. The IOLs comprise a lens body sized and adapted for placement in the mammalian eye and having a baseline optical power and at least one optical add power, preferably a plurality of different optical add powers. At least one of the optical add powers, preferably each of the optical add powers of the lens body has a magnitude so that the lens body when placed in the mammalian eye, in combination with the natural lens, provides enhanced vision. This enhanced vision continues as the accommodative capability of the natural lens in the eye decreases. Thus, the magnitude of the add power or powers of the lens body may provide only partial restoration of full accommodation in and of itself. However, when combined with the residual natural accommodative ability in the early presbyope, such IOL provides enhanced vision, for example, enhanced, or even substantially full, near vision or reading vision ability. Even after the early or partial presbyopic subject or presbyope progresses to full or absolute presbyopia, often after more than about five (5) or about ten (10) or about twenty (20) or more years, the reduced add power or powers of the present IOLs provide enhanced vision, for example, at intermediate distances.
- The IOLs in accordance with the present invention preferably provide a range of optical powers to allow focusing of distance, intermediate and near images on the retina. In one very useful embodiment the IOL has a simultaneous vision design, that is a concentric and cylindrically symmetric series of zones, such as annular zones, of varying optical power which provide additional or add power for vision at other than distance.
- The designed principal optical add power, in particular a near optical power, of the present IOLs preferably is less than the full optical power required for near reading in a pseudophakic subject, that is a subject not having a natural lens in place. This reduced power preferably is less than about 2.5 diopters in the spectacle plane. In a very useful embodiment, the designed principal optical add power of the IOL is reduced, which, in turn, reduces the effects of halos around lights at night while providing acceptable near and/or intermediate vision correction.
- The present IOLs preferably provide continuous visual correction or enhancement from distance to near for early (or partial) presbyopes. However, late or absolute presbyopes gradually find a reduction in near vision capabilities employing the present IOLs. Thus, such late, or absolute, presbyopes may require additional vision, e.g., spectacle, assistance for specific near reading tasks. Regardless of the eventual loss of near vision, the additional optical power required for near work is less than that which would be required without the present IOLs. This reduced optical power requirement allows the use of bifocals or progressive spectacles which have fewer field distortions, image jumping and other deleterious visual effects.
- The present IOLs may be placed at any position along the optical axis of the eye. For example, the present IOLs can be carried by or secured to the cornea of the eye, for example, such as a corneal implant, e.g., inlay or onlay. Also, the IOLs can be placed posterior of the posterior chamber. The present IOLs may further comprise a fixation member or members coupled to the lens body and adapted to facilitate fixating the IOL in the eye. The fixation member or members preferably are adapted to be placed in the anterior chamber of a mammalian eye or in the posterior chamber of a mammalian eye.
- The more likely locations for the present IOLs are in the anterior chamber, for example, with a fixation member or members in the angle of the eye; in the anterior chamber, for example, with a fixation member or members located in contact with the peripheral iris; in the anterior chamber with a fixation member or members located through the iris into the posterior chamber and in contact with the sulcus; or the posterior chamber between the iris and the natural lens with a fixation member or members in contact with the sulcus.
- The design of the present IOLS preferably provides that the lens body include a plurality of different regions each having an optical power, for example, a different optical power. The lens body may include a plurality of annular regions each having an optical power and extending radially outwardly from the central axis of the lens body. The lens body preferably is generally circular around the optical axis of the lens body, although other configurations and shapes may be employed and are within the scope of the present invention.
- The lens body preferably is configured so that at least one of the optical add powers is reduced by at least about 10%, and more preferably at least about 20% (in terms of diopters from a baseline distance correction optical power) relative to the corresponding optical power of the similar IOL adapted for placement in a similar eye in which a natural lens has been removed. Still more preferably, each of the add powers in the lens body is reduced by at least about 10% and even more preferably at least about 20%, relative to the corresponding optical power of the similar IOL adapted for placement in a similar eye in which the natural lens has been removed.
- The present lens bodies preferably are deformable for insertion through a small incision into the mammalian eye. The lens bodies preferably comprise a polymeric material.
- In another broad aspect of the present invention, methods for treating presbyopia in a mammalian eye including a natural lens are provided. Such methods provide for placing in the mammalian eye an IOL including a lens body having a baseline optical power and at least one optical add power, preferably, a plurality of different optical add powers, so that the lens body, in cooperation or combination with the natural lens, provides enhanced vision. Intraocular lenses as described herein may be employed in the present methods. The enhanced vision provided by such methods preferably is relative to the vision provided by the mammalian eye without the intraocular lens. The enhanced vision provided preferably is enhanced near vision, particularly in early or partial presbyopes. As noted above, as the subject progresses to full or absolute presbyopia, the enhanced vision provided by the present methods preferably is enhanced intermediate vision.
- Each and every feature described herein, and each and every combination of two or more of such features, is included within the scope of the present invention provided that the features included in such a combination are not mutually inconsistent.
- These and other aspects of the present invention are apparent in the following detained description and claims, particularly when considered in conjunction with the accompanying drawings in which like parts bear like reference numerals.
- FIG. 1 is a side elevation view of an eye with an anterior chamber intraocular lens in accordance with the present invention implanted therein.
- FIG. 2 is a front plan view of the anterior chamber intraocular lens shown in FIG. 1.
- FIG. 3 is a plot of the power of the lens body of the intraocular lens shown in FIG. 1 versus distance from the optical axis of the intraocular lens.
- FIG. 4 is a side elavational view of an eye with a posterior intraocular lens in accordance with the present invention implanted therein.
- FIG. 5 is a perspective view of the intraocular lens shown in FIG. 4.
- FIG. 6 is a side elevational view of an eye with another embodiment of an intraocular lens in accordance with the present invention implanted therein.
- FIG. 7 is a perspective view of the intraocular lens shown in FIG. 6.
- Referring now to FIGS. 1, 2 and3, an intraocular lens (IOL) according to the present invention, shown generally at 10, includes a
multifocal lens body 12 having a plurality of optical powers, as described hereinafter. Radially extending fixation members orhaptics 14 terminate in distal ends 16. As shown in FIG. 1,intraocular lens 10 is inserted in theanterior chamber 18 ofeye 20 with the distal ends 16 offixation members 14 in contact with theangle 22 of theiris 24. - Any number of configurations can be employed for distal ends16 of
fixation members 14 in order to provide for effective fixation ofintraocular lens 10 inanterior chamber 18. However, it is important that the configuration chosen be effective to provide for such fixation while, at the same time, not having an undue detrimental effect on the angle of the anterior chamber or on other components ofeye 20. This is particularly true here since theintraocular lens 10 is useful in eyes suffering from the early stages of presbyopia. Thus, theintraocular lens 10 should be designed and configured for long term use, for example, in excess of about ten (10) or about twenty (20) or thirty (30) years or more, ineye 20. various designs of fixation members have been suggested in the prior art to minimize the detrimental effects of having an intraocular lens in the anterior chamber of the eye. D-2821 9 Such designs may be employed in the present invention to achieve long term effectiveness of the present IOLs with reduced detriment to the eye caused by the presence of the intraocular lens. Thefixation members 14 can be made of materials of construction, such as polymeric materials, for example, polypropylene, polymethyl methacrylate and the like, many of which are conventionally used in intraocular lens haptics. - The
lens body 12 may be constructed of rigid biocompatible materials such as polymethyl methacrylate (PMMA), or flexible, deformable materials, such as silicone polymeric material, acrylic polymeric material, hydrogel polymeric material and the like, which enable the lens body to be rolled or folded before insertion through a small incision into theeye 20. Although thelens body 12 as shown is a refractive lens body, the present IOLs can include a diffractive lens body and such embodiment is included within the scope of the present invention. In addition, the power curve oflens body 12, seen in FIG. 3, is illustrative, but not limiting, of the present invention. In other words, lens bodies or optics in accordance with the present invention can have any suitable configurations and/or power curves effective to function, for example, to provide one or more benefits, as described herein. - One important aspect of
IOL 10 relates to the reduced add power of the optical powers oflens body 12. This can be seen in FIG. 3. The power curve for thelens body 12 is shown as a solid line in FIG. 3. Specifically, the add power or magnitude of the optical power relative to the baseline or “X” axis of FIG. 3 is reduced relative to the add power of a similar lens body, shown in dashed lines in FIG. 3, of a similar IOL adapted for use in an eye in which the natural lens has been removed. Thus, the optical power of thelens body 12 remains relatively closer to the baseline power (defined as the “X” axis in FIG. 3) as compared to the optical power of a similar lens body adapted for use in an eye in which the natural lens has been removed. Although the amount of reduction in the add power (relative to the above-noted similar lens adapted for use in an eye in which the natural lens has been removed) may be as little as about 10% or about 20%, such reduction in the add power is often greater than about 20% and can be in the range of about 30% to about 50% or more. - This reduced add power of
lens body 12, particularly with regard to near and/or intermediate vision correction regions, is of substantial importance in the present invention since thenatural lens 50 often retains a degree of natural accommodating ability. - Thus,
IOL 10 is very effective when inserted into an eye of an early presbyope, that is into the eye of a subject (e.g., human) who suffers a degree of, but not total, presbyopia. The reduced add power ofIOL 10 is effective, in combination with the remaining or residual accommodating ability of thenatural lens 50, to provide for substantially full accommodation, particularly in the early presbyope in which the loss of accommodating ability is less than about 20% or about 30% or about 50%. The add powers of thelens body 12 are determined, controlled or based, at least in part, by one or more of the following factors: the degree of residual or remaining accommodating ability of thenatural lens 50, the age of the subject in whose eye theIOL 10 is to be inserted, the vision needs of the subject, and the expected or anticipated life span of the subject, among other factors many of which are personal to the subject. Thus, thepresent IOL 10 is often customized to meet the specific and individual needs of the subject in whose eye theIOL 10 is to be inserted. - Thus, for the early or partial presbyope, the
lens body 12 provides enhanced vision, particularly for near objects which such early presbyopes often have difficulty in viewing. Such enhanced near vision is provided without the need for spectacles or other vision aids which can have at least a perceived detrimental effect on the appearance of the subject. - Further, even after the
natural lens 50 has lost a more substantial portion or even all of its accommodating ability, theIOL 10 continues to provide enhanced vision, for example, enhanced vision in viewing objects at intermediate distances. The later or substantially complete presbyope may require spectacles for viewing near objects. However, the presence ofIOL 10 in theeye 20 allows use of bifocals and progressive spectacles which have reduced field distortions, image “jumping” and other detrimental visual effects. - An additional advantage of the reduced add power of
IOL 10 is a reduction in the effects of halos around lights, for example, when viewed from a distance, at night. - One particular advantage of the
anterior chamber IOL 10 shown in FIG. 1 is that a substantial distance is maintained between thenatural lens 50 and thelens body 12. This distance is very effective in providing protection against theIOL 10 touching and possibly harming thenatural lens 50. - In the embodiment of FIGS. 1 and 2, the
lens body 12 has a convex anterior surface 25 and aplanar posterior surface 27; however, these configurations are merely illustrative. Although the vision correction power may be placed on either of thesurfaces 25 or 27, in this embodiment, the anterior surface 25 is appropriately shaped to provide the desired vision correction powers. - With particular reference to FIG. 3, the
lens body 12 has acentral zone 28, inner and outer annular nearzones far zones central zone 28 is circular and the peripheries of the annular zones 29-33 are circular. The annular zones 29-33 circumscribe thecentral zone 28 and the zones are contiguous. The zones 29-33 are concentric and coaxial with thelens body 12. - The zones28-33 are used in describing the vision correction power of the
lens body 12, and they are arbitrarily defined. - FIG. 3 shows a preferred manner in which the vision correction power of the
lens body 12 varies from the center oroptical axis 39 of the lens body to the circularouter periphery 41 of the lens body. In FIG. 3, the vertical or “Y” axis represents the variation in diopter power of thelens body 12 from the baseline or far vision correction power, and the “X” or horizontal axis shows the distance outwardly from theoptical axis 39, for example, in millimeters. Thus, the zero-diopter or baseline power of FIG. 3 is the power required for far vision for an IOL. The power variation shown in FIG. 3 is applicable to any surface point onlens body 12 at a fixed radial distance from theoptical axis 39. In other words, the power at any given radial distance from theoptical axis 39 is the same. - The
central zone 28 extends from theoptical axis 39 to acircular periphery 43, the inner annular nearzone 29 is considered as extending from theperiphery 43 to acircular periphery 44, and the outer annular near zone is considered as extending from aperiphery 45 to aperiphery 46. The annularfar zone 31 extends between theperipheries far zone 32 extends from theperiphery 46 radially outwardly to aperiphery 47. Theannular zone 33 extends from theperiphery 47 radially outwardly to theouter periphery 41 of thelens body 22. - The negative diopter powers at the optical axis and the
point 49 are of less power than is required for far vision and may be considered as far, far vision correction powers. The actual correction provided by the plurality of optical powers will vary and depends, for example, on the amount of residual accommodative ability present innatural lens 50, among other factors. - The apex48 has a vision correction power for intermediate vision. The intermediate, far and far, far powers combine to provide a mean power in the
central zone 28 for far or distant vision. - Within the inner annular near
zone 29, the vision correction power varies from theperiphery 43 to aplateau 51, and from the plateau, the vision correction power varies back to theperiphery 44 at the baseline. In thefar zone 31, the vision correction power increases very slightly above the baseline and then proceeds to a far, far negative vision correction power at apoint 53 at which the vision correction power reverses and returns to the baseline at theperiphery 45. - In the outer annular near
zone 30, the power varies from theperiphery 45 to aplateau 55 and returns from theplateau 55 to the baseline at theperiphery 46. In thefar zone 32, the power dips slightly below the baseline to apoint 57 in the far, far correction region and then returns to the baseline at theouter periphery 47. The dips below the baseline to thepoints far zones central zone 28. - The
far zone 33 has a vision power that lies along the baseline and is configured for far vision. - An alternate embodiment of an IOL in accordance with the present invention is shown in FIGS. 4 and 5. Except as expressly described herein, this alternate IOL, shown generally at110, is structured and functions similarly to
IOL 10. Components ofIOL 110 which correspond to components ofIOL 10 are indicated by the same reference numeral increased by 100. - The primary difference between
IOL 110 andIOL 10 relates to positioning within the eye. Specifically,IOL 110 is adapted to be placed in theposterior chamber 59, that is behind theiris 124 ofeye 120. This is beneficial in that the haptics orfixation members 114 contact the eye at thesulcus 60 which is substantially more resistant to damage than is the angle of the iris in the anterior chamber. Thus, thefixation members 114 are less likely to cause damage to the eye than are thefixation members 14 ofIOL 10. This is important since the IOLs in accordance with the present invention are often to be used on a long term basis, e.g., for about twenty (20) or about thirty (30) or more years. - The
fixation members 114, because of their placement, may be somewhat different in structure than thefixation members 14. - In addition, as shown best in FIG. 4, the
lens body 112 is a convex/concave lens. Theconcave posterior face 127 is so configured to provide some degree of space betweennatural lens 150 andlens body 112. Again, it is important that thelens body 112 be spaced apart from thenatural lens 150 in order to avoid damaging the natural lens. The multifocal structure of thelens body 112 preferably is present on the convexanterior face 125 of thelens body 112. -
IOL 110 performs substantially similarly toIOL 10, to provide enhanced vision both for the early presbyope subject and the subject who is in the later stages of presbyopia or is a substantially full or complete presbyope, as described above. - FIGS. 6 and 7 show another embodiment of an IOL in accordance with the present invention. Except as expressly described herein, this further embodiment of the present IOLs, shown as210, is structured and functions similarly to
IOL 10. Components ofIOL 210 which correspond to components ofIOL 10 are indicated by the same reference numeral increased by 200. - In general, the further embodiment of
IOL 210 provides that thelens body 212 is located in the anterior chamber but the fixation members are structured so as to contact thesulcus 62 in theposterior chamber 64 of theeye 220. This feature provides for both increased spacing between thelens body 212 and thenatural lens 250 and, in addition, allows thefixation members 214 to come in contact with the moresturdy sulcus 62 in fixating theIOL 210 in theeye 220. - FIG. 7 shows
IOL 210 comprised of alens body 212, and two opposing elongated fixation members orhaptics 214. Eachfixation 214 has aproximal segment 66 attached to thelens body 212 near the periphery of the lens body. Each fixation member also has adistal segment 68 and anintermediate segment 70 joining theproximal segment 66 and the distal segment. Thedistal segment 70 preferably is more flexible than the other portions of each of thefixation member 214. For example,distal segment 68 can have a reduced cross-sectional area relative to the cross-sectional areas ofintermediate segment 70 andproximal segment 66. - The
lens body 212 in the shown embodiment is circular in plan and bi-convex. - Each
fixation member 214 defines an arc that extends generally normal to theoptical axis 239. Each has a discontinuity or a through-iris portion 72 of theintermediate segment 70. The through-iris portion 72 extends generally parallel to theoptical axis 239. Other embodiments of the invention may have other suitable arrangements for thefixation members 214 and the through-iris portions 72. In the shown embodiment, thehaptics 214 are symmetrical. Other embodiments of the invention may have non-symmetrical fixation members. In the shown embodiment of the invention, thefixation members 214 extend generally tangentially away from the lens body. Other embodiments of the invention may havefixation members 214 attached to thelens body 212 which extend in a non-tangential fashion. - The through-
iris portions 72 may extend in any suitable direction other than normal to theoptical axis 239. In the shown embodiment of the invention, each through-iris portion 72 includes a straight member extending generally parallel to theoptical axis 239. - Referring now to FIG. 6, the
IOL 210 is shown implanted in theeye 220. Prior to implantation, an iridotomy is performed to form theholes 80 that extend through theiris 224 near the outer periphery of the iris. The iridotomy holes improve fluid flow between theanterior chamber 218 and theposterior chamber 64. Theholes 80, as shown, extend through theiris 224 generally parallel to theoptical axis 239. - The
IOL 210 is implanted such that thelens body 212 and theproximal segments 66 of thefixation members 214 are disposed in theanterior chamber 218. With thelens body 212 in theanterior chamber 218, there is a reduced opportunity for theIOL 210 to contact thenatural lens 250 and initiate papillary block and cataract formation. Further, thedistal segments 68 offixation members 214 are disposed in theposterior chamber 64 against thesulcus 62, which reduces the incidence of harm to the angle of the anterior chamber. - Further details of IOLs having fixation members and being positioned in the eye as
IOL 210 are provided in commonly assigned U.S. Patent application Ser. No. 09/166,328 filed Oct. 5, 1998, the disclosure of which is incorporated herein in its entirety by reference. -
IOL 210 performs substantially similarly toIOL 10, to provide enhanced vision both for the early presbyope subject and the subject who is in the later stages of presbyopia or is a substantially full or complete presbyope, as described above. - The present IOLs very effectively provide for enhanced vision for presbyopes whether in the early or partial stages of the condition or in the latter or even substantially complete stages. Thus, because of the reduced powers of the present multifocal lens bodies, the present IOIs can be implanted into an eye having an early or partial form of presbyopia. At this stage, the reduced optical power or powers, in combination with the remaining accommodation ability of the natural lens in the eye, preferably provide for a restoration of full accommodation so that the subject can read and perform other near vision activities without the need for spectacles or other vision aids. As the presbyopia progresses over time with advancing age of the subject, the amount of residual accommodation in the natural lens continues to be reduced. However, the present IOLs are very effective in providing for enhanced vision to the subject, particularly at intermediate distances. At this stage, reading or other near vision activities may require spectacles. Also, because the present IOLs are designed to maintain the eye in good condition and the natural lens in good condition, there is reduced risk that further ocular surgery will be required, for example, to remove the natural lens.
- While this invention has been described with respect to various specific examples and embodiments, it is to be understood that the invention is not limited thereto and that it can be variously practiced within the scope of the following claims.
Claims (25)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/960,032 US20020016630A1 (en) | 1999-04-30 | 2001-09-20 | Multifocal phakic intraocular lens |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/302,977 US6790232B1 (en) | 1999-04-30 | 1999-04-30 | Multifocal phakic intraocular lens |
US09/960,032 US20020016630A1 (en) | 1999-04-30 | 2001-09-20 | Multifocal phakic intraocular lens |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/302,977 Continuation US6790232B1 (en) | 1999-04-30 | 1999-04-30 | Multifocal phakic intraocular lens |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020016630A1 true US20020016630A1 (en) | 2002-02-07 |
Family
ID=23170058
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/302,977 Expired - Lifetime US6790232B1 (en) | 1999-04-30 | 1999-04-30 | Multifocal phakic intraocular lens |
US09/960,032 Abandoned US20020016630A1 (en) | 1999-04-30 | 2001-09-20 | Multifocal phakic intraocular lens |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/302,977 Expired - Lifetime US6790232B1 (en) | 1999-04-30 | 1999-04-30 | Multifocal phakic intraocular lens |
Country Status (6)
Country | Link |
---|---|
US (2) | US6790232B1 (en) |
EP (1) | EP1176929B1 (en) |
AT (1) | ATE262859T1 (en) |
AU (1) | AU4685800A (en) |
DE (1) | DE60009479T2 (en) |
WO (1) | WO2000066039A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040193264A1 (en) * | 2003-03-31 | 2004-09-30 | Richard Lindstrom | Compound AC IOL system |
US20040252274A1 (en) * | 2003-06-16 | 2004-12-16 | Morris G. Michael | Bifocal multiorder diffractive lenses for vision correction |
US7025456B2 (en) | 2004-08-20 | 2006-04-11 | Apollo Optical Systems, Llc | Diffractive lenses for vision correction |
US7156516B2 (en) | 2004-08-20 | 2007-01-02 | Apollo Optical Systems Llc | Diffractive lenses for vision correction |
US20100321632A1 (en) * | 2006-12-27 | 2010-12-23 | Demas Sanger | Multifocal ophthalmic lens |
US9220590B2 (en) | 2010-06-10 | 2015-12-29 | Z Lens, Llc | Accommodative intraocular lens and method of improving accommodation |
US9364318B2 (en) | 2012-05-10 | 2016-06-14 | Z Lens, Llc | Accommodative-disaccommodative intraocular lens |
US10512535B2 (en) | 2016-08-24 | 2019-12-24 | Z Lens, Llc | Dual mode accommodative-disaccomodative intraocular lens |
EP2105783B1 (en) * | 2001-04-11 | 2021-10-06 | AMO Groningen B.V. | An ophthalmic lens |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6152958A (en) * | 1998-12-16 | 2000-11-28 | Nordan; Lee T. | Foldable thin intraocular membrane |
US20060238702A1 (en) | 1999-04-30 | 2006-10-26 | Advanced Medical Optics, Inc. | Ophthalmic lens combinations |
US20030060881A1 (en) | 1999-04-30 | 2003-03-27 | Advanced Medical Optics, Inc. | Intraocular lens combinations |
US6547822B1 (en) * | 2000-05-03 | 2003-04-15 | Advanced Medical Optics, Inc. | Opthalmic lens systems |
US6554859B1 (en) * | 2000-05-03 | 2003-04-29 | Advanced Medical Optics, Inc. | Accommodating, reduced ADD power multifocal intraocular lenses |
US20120016349A1 (en) | 2001-01-29 | 2012-01-19 | Amo Development, Llc. | Hybrid ophthalmic interface apparatus and method of interfacing a surgical laser with an eye |
IL141529A0 (en) * | 2001-02-20 | 2002-03-10 | Ben Nun Yehoshua | Intraocular lens with scleral fixation capability |
US6576012B2 (en) * | 2001-03-28 | 2003-06-10 | Advanced Medical Optics, Inc. | Binocular lens systems |
JP4213881B2 (en) | 2001-07-09 | 2009-01-21 | 株式会社ニデック | Intraocular lens |
IL145015A0 (en) | 2001-08-21 | 2002-06-30 | Nun Yehoshua Ben | Accommodating lens |
US7763069B2 (en) | 2002-01-14 | 2010-07-27 | Abbott Medical Optics Inc. | Accommodating intraocular lens with outer support structure |
US20040082993A1 (en) | 2002-10-25 | 2004-04-29 | Randall Woods | Capsular intraocular lens implant having a refractive liquid therein |
US7662180B2 (en) | 2002-12-05 | 2010-02-16 | Abbott Medical Optics Inc. | Accommodating intraocular lens and method of manufacture thereof |
US20050131535A1 (en) | 2003-12-15 | 2005-06-16 | Randall Woods | Intraocular lens implant having posterior bendable optic |
IL161706A0 (en) * | 2004-04-29 | 2004-09-27 | Nulens Ltd | Intraocular lens fixation device |
US7815678B2 (en) * | 2004-10-13 | 2010-10-19 | Nulens Ltd. | Accommodating intraocular lens (AIOL), and AIOL assemblies including same |
US20080300680A1 (en) | 2005-03-30 | 2008-12-04 | Nulens Ltd | Accommodating Intraocular Lens (Aiol) and Discrete Components Therefor |
US9636213B2 (en) | 2005-09-30 | 2017-05-02 | Abbott Medical Optics Inc. | Deformable intraocular lenses and lens systems |
US20080161914A1 (en) | 2006-12-29 | 2008-07-03 | Advanced Medical Optics, Inc. | Pre-stressed haptic for accommodating intraocular lens |
US7713299B2 (en) | 2006-12-29 | 2010-05-11 | Abbott Medical Optics Inc. | Haptic for accommodating intraocular lens |
CA2674018C (en) | 2006-12-29 | 2015-05-26 | Advanced Medical Optics, Inc. | Multifocal accommodating intraocular lens |
USD702346S1 (en) | 2007-03-05 | 2014-04-08 | Nulens Ltd. | Haptic end plate for use in an intraocular assembly |
ATE483427T1 (en) * | 2007-03-05 | 2010-10-15 | Nulens Ltd | UNIFORM ACCOMMODATION INTRAOCULAR LENSES (AIOLS) AND DISCRETE BASE ELEMENTS FOR USE THEREWITH |
WO2009042289A1 (en) | 2007-08-02 | 2009-04-02 | Ocular Optics, Inc. | Multi-focal intraocular lens system and methods |
US20090059163A1 (en) * | 2007-08-30 | 2009-03-05 | Pinto Candido D | Ophthalmic Lens Having Selected Spherochromatic Control and Methods |
US8414646B2 (en) | 2007-12-27 | 2013-04-09 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
US8167941B2 (en) | 2008-01-03 | 2012-05-01 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
US8034108B2 (en) | 2008-03-28 | 2011-10-11 | Abbott Medical Optics Inc. | Intraocular lens having a haptic that includes a cap |
US20100004741A1 (en) * | 2008-07-03 | 2010-01-07 | Ocular Optics, Inc. | Sensor for detecting accommodative trigger |
ES2377456T3 (en) | 2008-07-24 | 2012-03-27 | Nulens Ltd | Accommodative intraocular lens capsules (IOLs) |
AU2010266022B2 (en) | 2009-06-26 | 2015-04-23 | Johnson & Johnson Surgical Vision, Inc. | Accommodating intraocular lenses |
CA2768145A1 (en) * | 2009-07-14 | 2011-01-20 | Elenza, Inc. | Folding designs for intraocular lenses |
WO2011017322A1 (en) | 2009-08-03 | 2011-02-10 | Abbott Medical Optics Inc. | Intraocular lens for providing accomodative vision |
US9259309B2 (en) | 2010-06-20 | 2016-02-16 | Elenza, Inc. | Ophthalmic devices and methods with application specific integrated circuits |
JP2013536008A (en) | 2010-07-26 | 2013-09-19 | エレンザ, インコーポレイテッド | Sealed ophthalmic device and method of making the same |
CA2810693A1 (en) | 2010-09-07 | 2012-03-15 | Elenza, Inc. | Installation and sealing of a battery on a thin glass wafer to supply power to an intraocular implant |
TWI588560B (en) | 2012-04-05 | 2017-06-21 | 布萊恩荷登視覺協會 | Lenses, devices, methods and systems for refractive error |
US9084674B2 (en) | 2012-05-02 | 2015-07-21 | Abbott Medical Optics Inc. | Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity |
US9201250B2 (en) | 2012-10-17 | 2015-12-01 | Brien Holden Vision Institute | Lenses, devices, methods and systems for refractive error |
CN104768499B (en) | 2012-10-17 | 2017-06-23 | 华柏恩视觉研究中心 | For ametropic eyeglass, device, method and system |
CN106461971B (en) | 2014-01-31 | 2019-06-14 | 欧福特克有限公司 | It is worn on the multifocal ophthalmic lens in eyes or on eyes |
JP6572311B2 (en) | 2014-09-09 | 2019-09-04 | スター サージカル カンパニー | Ophthalmic implant with extended depth of field and improved distance vision |
WO2017039672A1 (en) | 2015-09-03 | 2017-03-09 | Elenza, Inc. | Rechargeable intraocular implant |
WO2017156077A1 (en) | 2016-03-09 | 2017-09-14 | Staar Surgical Company | Ophthalmic implants with extended depth of field and enhanced distance visual acuity |
IL245775A0 (en) | 2016-05-22 | 2016-08-31 | Joshua Ben Nun | Hybrid accommodating intraocular lens |
AU2018330604A1 (en) | 2017-09-11 | 2020-04-02 | Amo Groningen B.V. | Methods and apparatuses to increase intraocular lenses positional stability |
ES2956033T3 (en) | 2018-08-17 | 2023-12-12 | Staar Surgical Co | Polymeric composition exhibiting refractive index nanogradient |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6199984B1 (en) * | 1999-03-17 | 2001-03-13 | Johnson & Johnson Vision Care, Inc. | Progressive addition lenses with varying power profiles |
US6457826B1 (en) * | 1998-08-06 | 2002-10-01 | John B. W. Lett | Multifocal aspheric lens |
Family Cites Families (164)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE25286E (en) | 1962-11-13 | Bifocal corneal contact lens | ||
US1483509A (en) | 1921-05-05 | 1924-02-12 | Franklin Optical Company | Process of making fused bifocal lenses |
US2129305A (en) | 1936-08-21 | 1938-09-06 | Feinbloom William | Contact lens |
US2274142A (en) | 1940-01-15 | 1942-02-24 | Revalens Co | Multifocal ophthalmic lens |
US2405989A (en) | 1941-08-12 | 1946-08-20 | Beach Lens Corp | Lens |
US2511517A (en) | 1947-01-31 | 1950-06-13 | Bell & Howell Co | Method of producing optical glass of varied refractive index |
US3031927A (en) | 1958-03-03 | 1962-05-01 | Plastic Contact Lens Company | Bifocal corneal contact lens |
US3034403A (en) | 1959-04-03 | 1962-05-15 | Neefe Hamilton Res Company | Contact lens of apparent variable light absorption |
US3227507A (en) | 1961-08-16 | 1966-01-04 | Feinbloom William | Corneal contact lens having inner ellipsoidal surface |
US3339997A (en) | 1962-07-30 | 1967-09-05 | Plastic Contact Lens Company | Bifocal ophthalmic lens having different color distance and near vision zones |
US3210894A (en) | 1962-08-13 | 1965-10-12 | Kollmorgen Corp | Method of producing aspheric surfaces on mirrors or lenses |
US3420006A (en) | 1964-01-27 | 1969-01-07 | Howard J Barnett | Apparatus for grinding multifocal lens |
US3431327A (en) | 1964-08-31 | 1969-03-04 | George F Tsuetaki | Method of making a bifocal contact lens with an embedded metal weight |
US3482906A (en) | 1965-10-04 | 1969-12-09 | David Volk | Aspheric corneal contact lens series |
US3542461A (en) | 1967-11-20 | 1970-11-24 | Du Pont | Contact lens having an index of refraction approximating that of human tears |
FR2097216A5 (en) | 1970-05-27 | 1972-03-03 | Anvar | |
US4055378A (en) | 1971-12-31 | 1977-10-25 | Agfa-Gevaert Aktiengesellschaft | Silicone contact lens with hydrophilic surface treatment |
CA1012392A (en) | 1973-08-16 | 1977-06-21 | American Optical Corporation | Progressive power ophthalmic lens |
US3922728A (en) | 1974-08-15 | 1975-12-02 | Krasnov Mikhail M | Artificial crystalline lens |
US3932148A (en) | 1975-01-21 | 1976-01-13 | Criterion Manufacturing Company, Inc. | Method and apparatus for making complex aspheric optical surfaces |
DE2610203B2 (en) | 1976-03-11 | 1981-01-22 | Optische Werke G. Rodenstock, 8000 Muenchen | Progressive lens |
DE2702117A1 (en) * | 1977-01-20 | 1978-07-27 | Soehnges Optik | Loose-seat contact lens - has surface structures on securing surface against corneal surface formed by moulding |
US4210391A (en) | 1977-09-14 | 1980-07-01 | Cohen Allen L | Multifocal zone plate |
US4162122A (en) | 1977-09-14 | 1979-07-24 | Cohen Allen L | Zonal bifocal contact lens |
US4195919A (en) | 1977-10-31 | 1980-04-01 | Shelton William A | Contact lens with reduced spherical aberration for aphakic eyes |
DE2814916C3 (en) | 1978-04-06 | 1982-01-07 | Optische Werke G. Rodenstock, 8000 München | Spectacle lens with a progression area located between the far part and the near part |
US4199231A (en) | 1978-08-21 | 1980-04-22 | Evans Carl H | Hydrogel contact lens |
US4253199A (en) | 1978-09-25 | 1981-03-03 | Surgical Design Corporation | Surgical method and apparatus for implants for the eye |
US4340283A (en) | 1978-12-18 | 1982-07-20 | Cohen Allen L | Phase shift multifocal zone plate |
US4338005A (en) | 1978-12-18 | 1982-07-06 | Cohen Allen L | Multifocal phase place |
US4254509A (en) | 1979-04-09 | 1981-03-10 | Tennant Jerald L | Accommodating intraocular implant |
US4274717A (en) | 1979-05-18 | 1981-06-23 | Younger Manufacturing Company | Ophthalmic progressive power lens and method of making same |
US4316293A (en) | 1979-08-27 | 1982-02-23 | Bayers Jon Herbert | Flexible intraocular lens |
US4418991A (en) | 1979-09-24 | 1983-12-06 | Breger Joseph L | Presbyopic contact lens |
US4307945A (en) | 1980-02-14 | 1981-12-29 | Itek Corporation | Progressively varying focal power opthalmic lens |
US4377329A (en) | 1980-02-26 | 1983-03-22 | Stanley Poler | Contact lens or the like |
USRE32525F1 (en) | 1980-04-01 | 1989-05-09 | Universal intraocular lens and a method of measuring an eye chamber size | |
US4370760A (en) | 1981-03-25 | 1983-02-01 | Kelman Charles D | Anterior chamber intraocular lens |
US4402579A (en) | 1981-07-29 | 1983-09-06 | Lynell Medical Technology Inc. | Contact-lens construction |
US4409691A (en) | 1981-11-02 | 1983-10-18 | Levy Chauncey F | Focussable intraocular lens |
US5776191A (en) | 1982-02-05 | 1998-07-07 | Staar Surgical Company | Fixation system for intraocular lens structures |
US4702244A (en) | 1982-02-05 | 1987-10-27 | Staar Surgical Company | Surgical device for implantation of a deformable intraocular lens |
US4404694A (en) | 1982-03-18 | 1983-09-20 | Kelman Charles D | Intraocular lens |
DE3222099C2 (en) | 1982-06-11 | 1984-06-20 | Titmus Eurocon Kontaktlinsen Gmbh & Co Kg, 8750 Aschaffenburg | Bifocal contact lens of the bivisual type |
GB2124500B (en) | 1982-07-22 | 1986-04-30 | Mazzocco Thomas R | Improved fixation system for intraocularers structures |
US4504982A (en) | 1982-08-05 | 1985-03-19 | Optical Radiation Corporation | Aspheric intraocular lens |
US4573775A (en) | 1982-08-19 | 1986-03-04 | Vistakon, Inc. | Bifocal contact lens |
US4888015A (en) | 1982-08-20 | 1989-12-19 | Domino Rudolph S | Method of replacing an eye lens |
EP0104832B1 (en) | 1982-09-29 | 1987-11-11 | Pilkington Brothers P.L.C. | Improvements in or relating to ophthalmic lenses |
US4476591A (en) | 1982-10-07 | 1984-10-16 | Arnott Eric J | Lens implants for insertion in the human eye |
DE3381691D1 (en) | 1982-10-13 | 1990-08-02 | Ng Trustees & Nominees Ltd | BIFOCAL CONTACT LENSES. |
US4890913A (en) | 1982-10-13 | 1990-01-02 | Carle John T De | Zoned multi-focal contact lens |
GB2129157B (en) | 1982-10-27 | 1986-02-05 | Pilkington Perkin Elmer Ltd | Bifocal contact lenses having defractive power |
DE3246306A1 (en) * | 1982-12-14 | 1984-06-14 | Titmus Eurocon Kontaktlinsen Gmbh & Co Kg, 8750 Aschaffenburg | Bifocal lens of bivisual type |
US4580882A (en) | 1983-04-21 | 1986-04-08 | Benjamin Nuchman | Continuously variable contact lens |
US4618229A (en) | 1983-07-22 | 1986-10-21 | Bausch & Lomb Incorporated | Bifocal contact lens |
US4551864A (en) | 1983-08-18 | 1985-11-12 | Iolab Corporation | Anterior chamber lens |
DE3332313A1 (en) | 1983-09-07 | 1985-04-04 | Titmus Eurocon Kontaktlinsen GmbH, 8750 Aschaffenburg | MULTIFOCAL, ESPECIALLY BIFOCAL, INTRAOCULAR ARTIFICIAL EYE LENS |
GB2146791B (en) | 1983-09-16 | 1987-01-28 | Suwa Seikosha Kk | Progressive multifocal ophthalmic lens |
US4636049A (en) | 1983-09-20 | 1987-01-13 | University Optical Products Co. | Concentric bifocal contact lens |
US4560383A (en) | 1983-10-27 | 1985-12-24 | Leiske Larry G | Anterior chamber intraocular lens |
US4687484A (en) | 1983-12-12 | 1987-08-18 | Kaplan Linda J | Anterior chamber intraocular lens |
US4596578A (en) | 1984-01-30 | 1986-06-24 | Kelman Charles D | Intraocular lens with miniature optic |
US4636211A (en) | 1984-03-13 | 1987-01-13 | Nielsen J Mchenry | Bifocal intra-ocular lens |
US4720286A (en) | 1984-07-20 | 1988-01-19 | Bailey Kelvin E | Multifocus intraocular lens |
US4976732A (en) | 1984-09-12 | 1990-12-11 | International Financial Associates Holdings, Inc. | Optical lens for the human eye |
US4725278A (en) | 1985-01-22 | 1988-02-16 | Shearing Steven P | Intraocular lens |
US4759762A (en) | 1985-03-08 | 1988-07-26 | Grendahl Dennis T | Accommodating lens |
US4693572A (en) | 1985-06-03 | 1987-09-15 | Fused Kontacts Of Chicago, Inc. | Monocentric bifocal corneal contact lens |
US4752123A (en) | 1985-11-19 | 1988-06-21 | University Optical Products Co. | Concentric bifocal contact lens with two distance power regions |
US4890912A (en) | 1986-01-24 | 1990-01-02 | Rients Visser | Trifocal eye-contact lens |
GB2192291B (en) | 1986-03-04 | 1990-08-22 | Gupta Anil K | Progressive power contact lens. |
US4725277A (en) | 1986-05-14 | 1988-02-16 | Precision-Cosmet Co., Inc. | Intraocular lens with tapered haptics |
EP0248489A3 (en) | 1986-06-02 | 1989-09-06 | Gregory N. Miller | Contact lens and method of making same |
US5192318A (en) | 1986-06-05 | 1993-03-09 | Schneider Richard T | One-piece bifocal intraocular lens construction |
US4676792A (en) | 1986-08-26 | 1987-06-30 | Donald Praeger | Method and artificial intraocular lens device for the phakic treatment of myopia |
US4842601A (en) | 1987-05-18 | 1989-06-27 | Smith S Gregory | Accommodating intraocular lens and method of implanting and using same |
US5201762A (en) | 1987-05-20 | 1993-04-13 | Hauber Frederick A | Intraocular archromatic lens |
US4790847A (en) | 1987-05-26 | 1988-12-13 | Woods Randall L | Intraocular lens implant having eye focusing capabilities |
US4898461A (en) | 1987-06-01 | 1990-02-06 | Valdemar Portney | Multifocal ophthalmic lens |
US5225858A (en) | 1987-06-01 | 1993-07-06 | Valdemar Portney | Multifocal ophthalmic lens |
US5166711A (en) | 1987-06-01 | 1992-11-24 | Valdemar Portney | Multifocal ophthalmic lens |
US5270744A (en) | 1987-06-01 | 1993-12-14 | Valdemar Portney | Multifocal ophthalmic lens |
US5166712A (en) | 1987-06-01 | 1992-11-24 | Valdemar Portney | Multifocal ophthalmic lens |
US5236452A (en) | 1987-07-02 | 1993-08-17 | Nordan Lee T | Intraocular multifocal lens |
US5074877A (en) | 1987-07-02 | 1991-12-24 | Nordan Lee T | Intraocular multifocal lens |
US4769033A (en) | 1987-07-02 | 1988-09-06 | Nordan Lee T | Intraocular multifocal lens |
US4917681A (en) | 1987-08-24 | 1990-04-17 | Nordan Lee T | Intraocular multifocal lens |
US5019099A (en) | 1987-07-02 | 1991-05-28 | Nordan Lee T | Intraocular multifocal lens method for correcting the aphakic eye |
US4932968A (en) | 1987-07-07 | 1990-06-12 | Caldwell Delmar R | Intraocular prostheses |
US4919663A (en) | 1987-08-24 | 1990-04-24 | Grendahl Dennis T | Laminated zone of focus artificial hydrogel lens |
US4921496A (en) | 1987-08-24 | 1990-05-01 | Grendahl Dennis T | Radially segemented zone of focus artificial hydrogel lens |
US4906246A (en) | 1987-08-24 | 1990-03-06 | Grendahl Dennis T | Cylindrically segmented zone of focus artificial hydrogel lens |
US5158572A (en) | 1987-09-10 | 1992-10-27 | Nielsen James Mchenry | Multifocal intraocular lens |
US5047052A (en) | 1987-11-06 | 1991-09-10 | Seymour Dubroff | Anterior chamber intraocular lens with four point fixation |
US4881804A (en) | 1987-11-12 | 1989-11-21 | Cohen Allen L | Multifocal phase plate with a pure refractive portion |
US4888012A (en) | 1988-01-14 | 1989-12-19 | Gerald Horn | Intraocular lens assemblies |
GB2215076A (en) | 1988-02-02 | 1989-09-13 | Dennis T Grendahl | Intraocular lens having a hard optic and a soft skirt |
IT1215851B (en) | 1988-02-11 | 1990-02-22 | Renato Liffredo | INTRAOCULAR LENS WITH CHROMATIC CORRECTION AND ABSORPTION DIAGRAM. |
CA1316728C (en) | 1988-04-01 | 1993-04-27 | Michael J. Simpson | Multi-focal diffractive ophthalmic lenses |
CS271606B1 (en) | 1988-04-11 | 1990-10-12 | Sulc Jiri | Intraocular optical system |
US5089024A (en) | 1988-04-19 | 1992-02-18 | Storz Instrument Company | Multi-focal intraocular lens |
FR2631228B1 (en) | 1988-05-11 | 1990-08-10 | Domilens Laboratoires | INTRA-EYE IMPLANT OF PREVIOUS CHAMBER |
US4932970A (en) | 1988-05-17 | 1990-06-12 | Allergan, Inc. | Ophthalmic lens |
US4923296A (en) | 1988-07-14 | 1990-05-08 | Erickson Paul M | Oriented simultaneous vision bifocal contact lenses or the like utilizing introaocular suppression of blur |
CN1020134C (en) | 1988-07-20 | 1993-03-17 | 艾伦·L·科恩 | Multifocal optical device |
US5192317A (en) | 1988-07-26 | 1993-03-09 | Irvin Kalb | Multi focal intra-ocular lens |
US4830481A (en) | 1988-08-12 | 1989-05-16 | Minnesota Mining And Manufacturing Company | Multifocal diffractive lens |
US4932966A (en) | 1988-08-15 | 1990-06-12 | Storz Instrument Company | Accommodating intraocular lens |
US4994082A (en) | 1988-09-09 | 1991-02-19 | Ophthalmic Ventures Limited Partnership | Accommodating intraocular lens |
US4990159A (en) | 1988-12-02 | 1991-02-05 | Kraff Manus C | Intraocular lens apparatus with haptics of varying cross-sectional areas |
US4892543A (en) | 1989-02-02 | 1990-01-09 | Turley Dana F | Intraocular lens providing accomodation |
FR2642854B1 (en) | 1989-02-03 | 1991-05-03 | Essilor Int | OPTICAL LENS WITH SIMULTANEOUS VISION FOR PRESBYTIA CORRECTION |
FR2647227B1 (en) | 1989-05-19 | 1991-08-23 | Essilor Int | OPTICAL COMPONENT, SUCH AS AN INTRAOCULAR IMPLANT OR CONTACT LENS, SUITABLE FOR CORRECTING THE VISION OF AN INDIVIDUAL |
US4955902A (en) | 1989-11-13 | 1990-09-11 | Kelman Charles D | Decentered intraocular lens |
US5002382A (en) | 1989-12-07 | 1991-03-26 | Leonard Seidner | Multifocal corneal contact lenses |
US5476514A (en) | 1990-04-27 | 1995-12-19 | Cumming; J. Stuart | Accommodating intraocular lens |
US5096285A (en) | 1990-05-14 | 1992-03-17 | Iolab Corporation | Multifocal multizone diffractive ophthalmic lenses |
US5147397A (en) | 1990-07-03 | 1992-09-15 | Allergan, Inc. | Intraocular lens and method for making same |
US5171266A (en) | 1990-09-04 | 1992-12-15 | Wiley Robert G | Variable power intraocular lens with astigmatism correction |
FR2666735A1 (en) | 1990-09-13 | 1992-03-20 | Klw | Intraocular implant with internal cavity |
US5173723A (en) | 1990-10-02 | 1992-12-22 | Volk Donald A | Aspheric ophthalmic accommodating lens design for intraocular lens and contact lens |
US5112351A (en) | 1990-10-12 | 1992-05-12 | Ioptex Research Inc. | Multifocal intraocular lenses |
US5260727A (en) | 1990-10-22 | 1993-11-09 | Oksman Henry C | Wide depth of focus intraocular and contact lenses |
FR2668362B1 (en) * | 1990-10-31 | 1997-12-05 | Corneal Ind | MULTIFOCAL LENS AND IN PARTICULAR BIFOCAL INTRAOCULAR IMPLANT WITH ALTERNATED AND PRIVILEGED VISION CORRECTION AREAS. |
US5258025A (en) | 1990-11-21 | 1993-11-02 | Fedorov Svjatoslav N | Corrective intraocular lens |
US5766244A (en) | 1991-05-23 | 1998-06-16 | Binder; Helmut | Intraocular artificial lens and method for fabricating same |
US5326347A (en) | 1991-08-12 | 1994-07-05 | Cumming J Stuart | Intraocular implants |
EP0601055B1 (en) | 1991-08-16 | 2000-06-07 | GALIN, Miles A. | Medicament coated refractive anterior chamber ocular implant |
US5578081A (en) | 1991-11-12 | 1996-11-26 | Henry H. McDonald | Eye muscle responsive artificial lens unit |
US5275623A (en) | 1991-11-18 | 1994-01-04 | Faezeh Sarfarazi | Elliptical accommodative intraocular lens for small incision surgery |
NL9200400A (en) | 1992-03-04 | 1993-10-01 | Jose Jorge Pavlotzky Handelend | BIFOCAL CONTACT LENS, AND METHOD FOR MANUFACTURING SUCH CONTACT LENSES |
US5443506A (en) | 1992-11-18 | 1995-08-22 | Garabet; Antoine L. | Lens with variable optical properties |
US5354335A (en) | 1993-02-04 | 1994-10-11 | Isaac Lipshitz | Intraocular insert for implantation in the human eye |
RU2033114C1 (en) | 1993-04-22 | 1995-04-20 | Межотраслевой научно-технический комплекс "Микрохирургия глаза" | Artificial crystalline lens |
US5489302A (en) | 1994-05-24 | 1996-02-06 | Skottun; Bernt C. | Accommodating intraocular lens |
JP3745394B2 (en) | 1994-07-04 | 2006-02-15 | 武敏 鈴木 | Intraocular lens |
WO1996010968A1 (en) * | 1994-10-06 | 1996-04-18 | Vladimir Feingold | Intraocular contact lens and method of implantation |
US6013101A (en) | 1994-11-21 | 2000-01-11 | Acuity (Israel) Limited | Accommodating intraocular lens implant |
US5549760A (en) | 1994-12-01 | 1996-08-27 | White Consolidated Industries, Inc. | Mounting device for dishwasher insulation |
US5574518A (en) | 1995-01-10 | 1996-11-12 | Les Laboratoires Opti-Centre Inc. | System incorporation two different sphero-non-spherical contact lenses for correcting presbytia |
US5628795A (en) | 1995-03-15 | 1997-05-13 | Langerman David W | Spare parts for use in ophthalmic surgical procedures |
US5652638A (en) | 1995-05-04 | 1997-07-29 | Johnson & Johnson Vision Products, Inc. | Concentric annular ring lens designs for astigmatism |
HUP9601126A3 (en) * | 1995-05-04 | 1999-10-28 | Johnson & Johnson Vision Prod | Concentric, aspheric, multifocal lens |
US5684560A (en) | 1995-05-04 | 1997-11-04 | Johnson & Johnson Vision Products, Inc. | Concentric ring single vision lens designs |
US5929969A (en) | 1995-05-04 | 1999-07-27 | Johnson & Johnson Vision Products, Inc. | Multifocal ophthalmic lens |
US5682223A (en) | 1995-05-04 | 1997-10-28 | Johnson & Johnson Vision Products, Inc. | Multifocal lens designs with intermediate optical powers |
US5607472A (en) | 1995-05-09 | 1997-03-04 | Emory University | Intraocular lens for restoring accommodation and allows adjustment of optical power |
US5864379A (en) * | 1996-09-27 | 1999-01-26 | Dunn; Stephen A. | Contact lens and process for fitting |
US5835192A (en) | 1995-12-21 | 1998-11-10 | Johnson & Johnson Vision Products, Inc. | Contact lenses and method of fitting contact lenses |
US5702440A (en) | 1996-01-26 | 1997-12-30 | Allergan | Multifocal ophthalmic lens for dim-lighting conditions |
FR2744908B1 (en) * | 1996-02-20 | 1998-06-12 | W K Et Associes | MYOPIC INTRAOCULAR IMPLANT |
US5864378A (en) | 1996-05-21 | 1999-01-26 | Allergan | Enhanced monofocal IOL or contact lens |
US5769890B1 (en) | 1997-01-16 | 2000-09-05 | Surgical Concepts Inc | Placement of second artificial lens in eye to correct for optical defects of first artificial lens in eye |
US5898473A (en) | 1997-04-25 | 1999-04-27 | Permeable Technologies, Inc. | Multifocal corneal contact lens |
US5928282A (en) * | 1997-06-13 | 1999-07-27 | Bausch & Lomb Surgical, Inc. | Intraocular lens |
US5928283A (en) | 1997-06-26 | 1999-07-27 | Visioncare Ltd | Telescopic device for an intraocular lens |
US5843188A (en) | 1997-10-20 | 1998-12-01 | Henry H. McDonald | Accommodative lens implantation |
US5814103A (en) | 1998-01-15 | 1998-09-29 | Visioncare Ltd. | Intraocular lens and telescope with mating fasteners |
US5876442A (en) | 1998-01-15 | 1999-03-02 | Visioncare Ltd. | Intraocular lens implant with telescope support |
US6231603B1 (en) | 1998-11-10 | 2001-05-15 | Allergan Sales, Inc. | Accommodating multifocal intraocular lens |
US6176878B1 (en) | 1998-12-17 | 2001-01-23 | Allergan Sales, Inc. | Accommodating intraocular lens |
US6197058B1 (en) * | 1999-03-22 | 2001-03-06 | Valdemar Portney | Corrective intraocular lens system and intraocular lenses and lens handling device therefor |
US6217612B1 (en) | 1999-09-10 | 2001-04-17 | Randall Woods | Intraocular lens implant having eye accommodating capabilities |
-
1999
- 1999-04-30 US US09/302,977 patent/US6790232B1/en not_active Expired - Lifetime
-
2000
- 2000-04-27 DE DE60009479T patent/DE60009479T2/en not_active Expired - Lifetime
- 2000-04-27 AU AU46858/00A patent/AU4685800A/en not_active Abandoned
- 2000-04-27 AT AT00928657T patent/ATE262859T1/en not_active IP Right Cessation
- 2000-04-27 WO PCT/US2000/011730 patent/WO2000066039A1/en active IP Right Grant
- 2000-04-27 EP EP00928657A patent/EP1176929B1/en not_active Expired - Lifetime
-
2001
- 2001-09-20 US US09/960,032 patent/US20020016630A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6457826B1 (en) * | 1998-08-06 | 2002-10-01 | John B. W. Lett | Multifocal aspheric lens |
US6199984B1 (en) * | 1999-03-17 | 2001-03-13 | Johnson & Johnson Vision Care, Inc. | Progressive addition lenses with varying power profiles |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2105783B1 (en) * | 2001-04-11 | 2021-10-06 | AMO Groningen B.V. | An ophthalmic lens |
US20040193264A1 (en) * | 2003-03-31 | 2004-09-30 | Richard Lindstrom | Compound AC IOL system |
US20040252274A1 (en) * | 2003-06-16 | 2004-12-16 | Morris G. Michael | Bifocal multiorder diffractive lenses for vision correction |
US6951391B2 (en) | 2003-06-16 | 2005-10-04 | Apollo Optical Systems Llc | Bifocal multiorder diffractive lenses for vision correction |
US20050264757A1 (en) * | 2003-06-16 | 2005-12-01 | Morris G M | Bifocal multiorder diffractive lenses for vision correction |
US7093938B2 (en) | 2003-06-16 | 2006-08-22 | Apollo Optical Systems Llc | Bifocal multiorder diffractive lenses for vision correction |
US7232218B2 (en) | 2003-06-16 | 2007-06-19 | Apollo Optical Systems, Inc. | Bifocal multiorder diffractive lenses for vision correction |
US7025456B2 (en) | 2004-08-20 | 2006-04-11 | Apollo Optical Systems, Llc | Diffractive lenses for vision correction |
US7156516B2 (en) | 2004-08-20 | 2007-01-02 | Apollo Optical Systems Llc | Diffractive lenses for vision correction |
US20100321632A1 (en) * | 2006-12-27 | 2010-12-23 | Demas Sanger | Multifocal ophthalmic lens |
US8079704B2 (en) * | 2006-12-27 | 2011-12-20 | Hoya Corporation | Multifocal ophthalmic lens |
US9220590B2 (en) | 2010-06-10 | 2015-12-29 | Z Lens, Llc | Accommodative intraocular lens and method of improving accommodation |
US10524900B2 (en) | 2010-06-10 | 2020-01-07 | Z Lens, Llc | Accommodative intraocular lens and method of improving accommodation |
US9364318B2 (en) | 2012-05-10 | 2016-06-14 | Z Lens, Llc | Accommodative-disaccommodative intraocular lens |
US10898317B2 (en) | 2012-05-10 | 2021-01-26 | Carl Zeiss Meditec Ag | Accommodative-disaccommodative intraocular lens |
US10512535B2 (en) | 2016-08-24 | 2019-12-24 | Z Lens, Llc | Dual mode accommodative-disaccomodative intraocular lens |
Also Published As
Publication number | Publication date |
---|---|
US6790232B1 (en) | 2004-09-14 |
WO2000066039A1 (en) | 2000-11-09 |
AU4685800A (en) | 2000-11-17 |
DE60009479D1 (en) | 2004-05-06 |
DE60009479T2 (en) | 2005-02-24 |
EP1176929B1 (en) | 2004-03-31 |
EP1176929A1 (en) | 2002-02-06 |
ATE262859T1 (en) | 2004-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6790232B1 (en) | Multifocal phakic intraocular lens | |
EP1278483B1 (en) | Accommodating, reduced add power multifocal intraocular lenses | |
US6824563B2 (en) | Binocular lens systems | |
US6503276B2 (en) | Accommodating multifocal intraocular lens | |
US6616692B1 (en) | Intraocular lens combinations | |
US6537317B1 (en) | Binocular lens systems | |
US6228115B1 (en) | Intraocular lenses with improved axial stability | |
US6461384B1 (en) | Intraocular lenses | |
AU2003220130B2 (en) | Accommodative intraocular lens | |
US5158572A (en) | Multifocal intraocular lens | |
US8425597B2 (en) | Accommodating intraocular lenses | |
US20020087210A1 (en) | Intraocular | |
AU2001259360A1 (en) | Accommodating, reduced add power multifocal intraocular lenses | |
CA2366818C (en) | Implant for correcting presbyopia in phakic eyes | |
US20050288784A1 (en) | Bifocal intraocular telescope for low vision correction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., NEW YORK Free format text: SECURITY AGREEMENT;ASSIGNORS:ADVANCED MEDICAL OPTICS, INC.;AMO HOLDINGS, LLC;REEL/FRAME:013203/0039 Effective date: 20020621 |
|
AS | Assignment |
Owner name: ADVANCED MEDICAL OPTICS, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ALLERGAN, INC.;REEL/FRAME:014446/0858 Effective date: 20030625 |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, CA Free format text: SECURITY AGREEMENT;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:014914/0692 Effective date: 20040625 Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT,CAL Free format text: SECURITY AGREEMENT;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:014914/0692 Effective date: 20040625 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: ADVANCED MEDICAL OPTICS, INC.,CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 14914/0692;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:019111/0815 Effective date: 20070402 Owner name: ADVANCED MEDICAL OPTICS, INC., CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 13203/0039;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:019111/0348 Effective date: 20070402 Owner name: ADVANCED MEDICAL OPTICS, INC., CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 14914/0692;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:019111/0815 Effective date: 20070402 Owner name: AMO HOLDINGS, INC. (FORMERLY KNOWN AS AMO HOLDINGS Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 13203/0039;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:019111/0348 Effective date: 20070402 |